1. Generation and characterization of Csrp1 enhancer-driven tissue-restricted Cre-recombinase mice.
- Author
-
Snider P, Fix JL, Rogers R, Peabody-Dowling G, Ingram D, Lilly B, and Conway SJ
- Subjects
- Animals, Cells, Cultured, Cloning, Molecular, Embryo, Mammalian, Female, Gene Expression Regulation, Developmental, Heart embryology, LIM Domain Proteins, Male, Mice, Mice, Inbred C3H, Mice, Inbred DBA, Muscle, Smooth, Vascular embryology, Muscle, Smooth, Vascular metabolism, Myocardium metabolism, Myocytes, Smooth Muscle metabolism, Neovascularization, Physiologic genetics, Nuclear Proteins metabolism, Organ Specificity, Proteins genetics, RNA, Untranslated, Enhancer Elements, Genetic physiology, Integrases genetics, Integrases metabolism, Mice, Transgenic, Nuclear Proteins genetics
- Abstract
Cell type-specific genetic modification using the LoxP/Cre system is a powerful tool for genetic analysis of distinct cell lineages. Because of the unique arterial smooth muscle-restricted expression of a 5.0 kb cysteine-rich protein (Csrp1) enhancer (Lilly et al.,2001, Dev Biol 240:531-547), we hypothesized that a transgenic Cre line would prove useful for the smooth muscle lineage-specific genetic manipulation. Here we describe a transgenic mouse line, ECsrp1(Cre), where Cre is initially specifically expressed in arterial smooth muscle cells. Use of the ROSA26R reporter allele confirmed that Cre-mediated recombination in vascular smooth muscle cells began at approximately E10.0 and was highly proficient. Subsequently, Cre is expressed in restricted skeletal and nonvascular smooth muscle lineages. This lineage tracing data is important for future conditional knockout studies to understand where and when Cre-mediated deletion occurs and where Cre-expressing daughter cells finally localize. Additionally, we crossed the ECsrp1(Cre) mice to the ROSA26(-eGFP-DTA) diphtheria toxin A-expressing mice to genetically ablate ECsrp1(Cre) expressing cells. This ECsrp1(Cre) transgenic line should thus prove useful for genetic analysis of diverse aspects of cardiovascular morphogenesis and as a general smooth muscle lineage deletor line., ((c) 2008 Wiley-Liss, Inc.)
- Published
- 2008
- Full Text
- View/download PDF